WASF2 inactivation decreased the viability, growth, proliferation, migration, and invasion of Huh-7 and SNU475 HCC cells, by inducing G2/M phase arrest, provoking HCC cell death, inhibiting EMT, and modulating actin polymerization. The gene discussed is WASF2; the disease is hepatocellular carcinoma.